Albareda, N., N. Rosenberg, S. Roth, I. Zsolt, T. Rosen, and A. A. Hebert. “Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Phase III Clinical Trials Pooled Analysis Results”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s102, doi:10.25251/skin.1.supp.101.